Drugs / AZD3839
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01348737 | Jun → Nov 2011 | Alzheimer disease | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD3839 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01348737 ↗ |
| Modality | Small molecule | — CHEMBL2177913 ↗ |
| Route | Oral | “following oral administration” NCT01348737 ↗ |